{
    "id": 31822,
    "fullName": "EZH2 A682G",
    "impact": "missense",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "EZH2 A682G lies within the SET domain of the Ezh2 protein (UniProt.org). A682G has been identified in the scientific literature (PMID: 24563539), but has not been biochemically characterized and therefore, its effect on Ezh2 protein function is unknown (PubMed, Dec 2019).",
            "references": [
                {
                    "id": 2725,
                    "pubMedId": 24563539,
                    "title": "Selective inhibition of EZH2 by EPZ-6438 leads to potent antitumor activity in EZH2-mutant non-Hodgkin lymphoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24563539"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 2146,
        "geneSymbol": "EZH2",
        "terms": [
            "EZH2",
            "ENX-1",
            "ENX1",
            "EZH2b",
            "KMT6",
            "KMT6A",
            "WVS",
            "WVS2"
        ]
    },
    "variant": "A682G",
    "createDate": "12/17/2019",
    "updateDate": "12/17/2019",
    "referenceTranscriptCoordinates": {
        "id": 185998,
        "transcript": "NM_001203249",
        "gDna": "chr7:g.148807689G>C",
        "cDna": "c.2045C>G",
        "protein": "p.A682G",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 19559,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, treatment with Tazemetostat (EPZ-6438) inhibited proliferation and induced apoptosis in lymphoma cell lines harboring EZH2 A682G in culture, and complete tumor regression in cell line xenograft models (PMID: 24563539).",
            "molecularProfile": {
                "id": 34219,
                "profileName": "EZH2 A682G"
            },
            "therapy": {
                "id": 2683,
                "therapyName": "Tazemetostat",
                "synonyms": null
            },
            "indication": {
                "id": 60058,
                "name": "lymphoma",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 2725,
                    "pubMedId": 24563539,
                    "title": "Selective inhibition of EZH2 by EPZ-6438 leads to potent antitumor activity in EZH2-mutant non-Hodgkin lymphoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24563539"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 34219,
            "profileName": "EZH2 A682G",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 185999,
            "transcript": "XM_011515884",
            "gDna": "chr7:g.148809375G>C",
            "cDna": "c.2045C>G",
            "protein": "p.A682G",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 185997,
            "transcript": "NM_004456",
            "gDna": "chr7:g.148809375G>C",
            "cDna": "c.2045C>G",
            "protein": "p.A682G",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 185998,
            "transcript": "NM_001203249",
            "gDna": "chr7:g.148807689G>C",
            "cDna": "c.2045C>G",
            "protein": "p.A682G",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}